Everyday Health on MSN
What to Do if Topical Treatments Aren’t Enough for Your Psoriasis
Topicals are often the first-line treatment for psoriasis, but as the condition progresses, you may need to consider systemic treatments to manage your symptoms. Here’s what to know about your options ...
Whether you suffer from psoriasis yourself or have heard about it from a famous Kardashian who has been very transparent about her symptoms, you know that the skin condition is far from glamorous and ...
A slightly more premium option, and one that includes the same colloidal oatmeal as the Aveeno cream above, Dr Armstrong ...
Hot off its first approval this summer in psoriasis, Arcutis Biotherapeutics’ roflumilast foam 0.3%, approved in cream form under the brand name Zoryve, is out to prove it’s no one-trick pony in itch.
Please provide your email address to receive an email when new articles are posted on . Arcutis Biotherapeutics announced positive results from two pivotal phase 3 studies evaluating Zoryve cream as a ...
Eczema and psoriasis come with similar symptoms and therefore can be easy to confuse. Here's how to differentiate the two.
Organon Canada, a global healthcare company with a mission to improve the health of women throughout their lives, announces the availability of NDUVRA (tapinarof cream), 1%, for the topical treatment ...
Arcutis Biotherapeutics has spent the weeks since the FDA approval of its topical plaque psoriasis cream Zoryve strengthening its cash position, drawing down $125 million from its loan facility and ...
Can cannabis be used as a medical substitute to treat psoriasis? This is what a recent study published in the Journal of Current Science and Technology hopes to determine as a team of researchers from ...
- 88.5% of adult patients achieved a target lesion Physician Global Assessment (tPGA) score of 0 (clear) or 1 (almost clear) and ≥ 2-grade improvement from baseline at Week 12 (tPGA Success), ...
Data from the INTEGUMENT trials demonstrates that ZORYVE cream 0.15% has a favorable safety profile and high tolerability, even among patients with prior inadequate responses to traditional treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results